Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Acute Myocardial Infarction to Prevent Heart Failure
NCT05177822Phase 2Active, not recruiting
- Sponsor
- Virginia Commonwealth University
- Start
- May 2022
- Primary completion
- Feb 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Anakinra with Placebo (2 arms). Primary endpoint: Peak oxygen consumption at 6 weeks. Started May 2022; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05177822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177822.